GUANGZHOU, China–(BUSINESS WIRE)– Bio-Thera Solutions, Ltd., a clinical-stage pharmaceutical company, today announced that the China National Medical Products Administration (NMPA) has approved its Investigational New Drug (IND) application to initiate a...
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today presented positive top-line results from its Phase 3 HARMONY study at the 12 th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting, December 4 -7, 2019 in San Diego, California. HARMONY was a double-blind,...
— Topline data expected in the fourth quarter of 2020 or early in the first quarter of 2021 — — Supplemental cohort continues enrollment to meet patient demand — BOSTON, Dec. 05, 2019 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc....
PHILADELPHIA, Dec. 4, 2019 /PRNewswire/ — Lannett Company, Inc. (NYSE: LCI) today announced positive results from the first human study evaluating insulin glargine that Lannett is developing with its strategic alliance partners within the HEC Group of companies...
ENGLEWOOD, Colo., Dec. 4, 2019 /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (SPA) Phase III clinical trial titled “Evaluating the Efficacy and...
Email
Text